Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
2.630
+0.260 (10.97%)
At close: Jan 9, 2026, 4:00 PM EST
2.580
-0.050 (-1.90%)
After-hours: Jan 9, 2026, 7:59 PM EST
Rezolute Market Cap
Rezolute has a market cap or net worth of $243.87 million as of January 9, 2026. Its market cap has decreased by -5.22% in one year.
Market Cap
243.87M
Enterprise Value
93.13M
1-Year Change
-5.22%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $243.87M, an increase of 46.03%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 243.90M | 11.47% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |